Bench bioprosthetic aortic valve replacement in a donor heart before transplantation

Soort studie: Descriptivo / Reporte de caso
Juan C. Rendón MD
Alejandro Quintero-Gómez
april 15, 2022
Startpagina: 1
DOI : 10.1111/jocs.16519
SJR: Q3
Full time
Full time
Full time
tijdschrift naam: Journal of Cardiac Surgery
eindpagina: 2
Onderzoekslijn: cardiovasculaire chirurgie
Is niet van toepassing
Otro

Critical donor shortages have impulsed the need to expand donor heart eligibility through the use of marginal hearts in cardiac transplantation. Donor valvular disease has been considered as an absolute contraindication for transplant. A 39-year-old male patient with end-stage non-compaction cardiomyopathy, an INTERMACS II heart failure, and a left ventricular ejection fraction of 8% was taken to an orthotopic heart transplantation. During donor bench graft examination, a congenital bicuspid and calcified aortic valve was found. The native bicuspid valve was removed and the annular calcification debrided; een #21 bioprosthetic aortic valve was then implanted.

%NS bloggers vinden dit leuk: